Blood-Grouping Reagents Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, France, Japan - Size and Forecast 2024-2028

Blood-Grouping Reagents Market Forecast 2024-2028

The global blood-grouping reagents market size is estimated to grow by USD 520.68 million, at a CAGR of 8.13% between 2023 and 2028. 

Global blood donation rates have surged with increasing awareness and the growing number of donors responding to the needs of patients requiring blood transfusions for conditions like severe anemia, liver, and kidney diseases, and hemophilia. Rising awareness of the benefits of donation, including emotional and physical health improvements like stress reduction and lowered heart disease risk, further drives participation. Consequently, more individuals are contributing to blood banks at hospitals and clinics, bolstering the supply of component products like reagents. This trend, influenced by factors such as chronic diseases, accidents, and advancements in blood safety and technology, is crucial in meeting the demands of end-users, including hospitals and clinics, and optimizing inventory management amidst rising healthcare expenditure.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation by End-user, Technique, and Geography Analysis

End-user Analysis

The market share by the hospitals and blood banks segment will be significant during the forecast period. Due to the high rate of use of these reagent products in hospitals and blood banks as a result of increased demand for transfusions, hospital segments represent the most significant part of the market. This high demand can be primarily attributed to increasing hospitalizations for cancer treatment and other chronic conditions and increasing emergency cases such as road accidents.

Get a glance at the market contribution of various segments Download PDF Sample

The hospital and blood bank segment was valued at USD 397.62 million in 2018. The emergency departments are always playing a key role in major tasks, such as diagnosis, triage, and identification of immediate treatment needs that need to be undertaken at short notice. An increased number of donation campaigns have been established as a result of an increase in public awareness about the provision of blood. Few factors are expected to contribute significantly to the demand for such reagents, owing to their increasing use among hospitals and blood banks.

Technique analysis 

The PCR-based and microarray techniques will account for the largest share of this segment. PCR (Polymerase Chain Reaction) is a widely used molecular biology technique that amplifies specific DNA sequences. Specific gene sequences related to antigen groups may be detected and amplified by PCR. The molecules on the surface of RBC are known as blood-group antigens. The microarray technique involves immobilizing thousands of specific DNA probes on a solid surface, allowing for the simultaneous detection of multiple DNA sequences.  Microarray technology can be applied for the detection and differentiation of different group antigens from one sample to another as part of a grouping. The techniques used offer advantages such as high sensitivity, and they have the ability to analyze multiple blood group antigens simultaneously. Hence this segment dominates the market in focus, and it will continue to grow during the forecast period.

Assay-based blood grouping techniques refer to methods used to determine an individual blood type based on the detection of specific antigens or antibodies in their blood. These techniques rely on the principles of antigen-antibody reaction and are commonly used in blood banks and clinical laboratories.  AntiA, antiB, and antiD antibodies are the most commonly used antibodies for forward typing. Reverse typing: This method tests the serum or plasma of a patient with known red blood cells that contain antigens on their surface. Their purpose is to determine the presence of specific antibodies in the patient that may react with the antigens on the red cells. The key to determining compatibility for transfusion is by means of a technique based on an assay called Assay Grouping. Hence this segment contributes towards the growth of the market in focus during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The growth of the market in this region is primarily driven by the sales of approved grouping reagents for group typing and the increasing prevalence of various chronic conditions and cancer types. A high prevalence of leukemia in the region subsequently increases the adoption of treatment options such as surgeries and therapeutics.  This group testing is required for cancer patients as they may require transfusion for treatment, especially in surgical procedures. The availability of a broad range of products, and thus driving the growth of the market in this area, can be attributed to the large number of US companies that sell blood group reagents.

Buy the Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

AliveDX: The company offers reagents such as ALBAclone Anti A, ALBAclone Anti B, ALBAlect Anti A1 lectin, ALBAclone Anti D blend.

• Arena Bio Scien
• ARKRAY Inc.
• Atlas Medical GmbH
• BAG Health Care GmbH
• Bio Rad Laboratories Inc.
• Calibre Scientific Inc.
• Danaher Corp.
• DIAGAST SAS
• Grifols SA
• Merck KGaA
• Novacyt SA
• QuidelOrtho Corp.
• Rapid Labs Ltd.
• Thermo Fisher Scientific Inc.
• Torax Biosciences Ltd.
• Tulip Diagnostics Pvt. Ltd.
• Fortress Diagnostics
• Paragon Care Ltd.
• VitroScient

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market encompasses products like antigens and antibodies used to determine an individual's blood group. Leading companies like Ortho Clinical Diagnostics contribute to this market, addressing factors like the Rh factor crucial for blood transfusions. With blood banks playing a pivotal role in ensuring blood safety, particularly for Americans, advancements in technology aid in inventory management and bolster healthcare expenditure. These reagents aid in diagnosing various conditions, including anemia, haemophilia, and blood cancers, thereby enabling effective treatment strategies for patients with chronic diseases or those involved in accidents requiring urgent blood donation. There are multiple factors influencing market growth and forecasting. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

The market is witnessing a significant uptick due to the escalating prevalence of chronic disorders. In recent years, the surge in chronic diseases such as diabetes and cancer has fueled the need for early diagnosis to enhance patient care outcomes. This demand is particularly pronounced in cancer patients who often require transfusions during treatment, as chemotherapy drugs can adversely affect bone marrow function, leading to low counts and heightened mortality rates.

Furthermore, the short shelf life of such products as platelets, vital for cancer treatment, has further spurred demand. Additionally, there is a growing interest among researchers in exploring the relationship between group biochemistry and disease risk, including conditions like asthma and chronic obstructive pulmonary disease (COPD). As a result, there is an increased requirement for grouping products and reagents to facilitate accurate diagnoses and potential therapeutic interventions. Consequently, the surge in chronic disease prevalence and the need for early diagnostic measures through grouping have become prominent drivers propelling the market growth.

Significant Market Trends

The increasing penetration of healthcare facilities is one of the market trends. The grouping of blood is one of the basic and major tests before starting a significant amount of other advanced testing. In developing economies, particularly in rural areas, the lack of healthcare infrastructure and adequate facilities for basic health information, such as blood grouping, is a challenge. As a result, public healthcare spending in India was 2,21 % of GDP in 2021 against 1,8 % in 2020, and various government bodies have undertaken certain initiatives aimed at increasing access to healthcare facilities.

Furthermore, regional government bodies are also undertaking initiatives pertaining to blood safety as it is becoming a concern for regulatory bodies to ensure universal access to safe blood. The development and implementation of national blood policies have been triggered by factors that include risks for transmissible disease, e.g. HIV, hepatitis B HBV HCV or syphilis; the lack of adequate staffing to deliver transfusion services; as well as a shortage of medical personnel who can carry out this service. The US FDA scientists are developing sensitive donor screening tests to detect emerging diseases and potential bioterrorism agents in donations. Hence, the increasing government initiatives pertaining to safety are expected to contribute to the growth of the global market.

Major Challenges

The risks associated with transfusion are a major challenge faced by the market. Blood transfusion plays a major role in replacing the lost during surgeries, injuries, or due to chemotherapy drug effects among cancer patients. The risks of complications during or following the transfusion are, however, associated with this procedure. An acute immune hematological reaction, in which an immune system attacks transfused RBCs when the donor type does not correspond to that of a good match, is one of the risks and complications associated with transfusion.

Moreover, another risk associated with the delayed reaction to hemolysis is a reduction of red blood cell counts over time. Some patients also experience mild or severe allergic reactions with symptoms such as anxiety, chest pain, back pain, fever, damp skin, and nausea during transfusions.  In addition, too many transfusions may cause a high amount of iron to build up in which is harmful to the liver, heart, and part of the body. Hence, the complications and risks arising as a result of blood transfusion are restricting the blood transfusion, which, in turn, is affecting the demand for blood grouping reagents.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2018. 

•  End-user Outlook
  • Hospitals and blood banks
  • Clinical laboratories
  • Academic and research institutes

• Technique Outlook
  • PCR-based and microarray techniques
  • Assay-based techniques
  • Massively parallel sequencing techniques
  • Serology

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the world (ROW)
    • Argentina
    • Australia 
    • Brazil

Market Analyst Overview

The market plays a critical role in the healthcare industry, providing essential tools for blood group typing and transfusion-related procedures. Ortho Clinical Diagnostics and other key players in this market offer a wide range of technologically advanced reagents and kits for accurate blood typing and antibody screening. Additionally, with a growing focus on healthcare expenditure and technological advancements, the market is witnessing increased demand for blood grouping reagents to address various medical conditions such as anaemia, hemophilia, and blood cancers. These reagents are vital for inventory management in healthcare facilities, especially in developing countries where access to advanced healthcare Research, medical devices research, and diagnostic devices research. is crucial. The market encompasses a range of serological fluids, molecular diagnostic test reagents, and consumables used for blood sample analysis and transplantation procedures.

Moreover, key test types include ABO blood tests, HLA typing, and cross-matching tests, essential for identifying compatible blood donors and recipients, as well as for detecting transfusion-transmitted infections (TTIs). Furthermore. as the population ages and the demand for organ transplantation grows, the need for accurate blood grouping reagents continues to rise. Market players like Arena BioScien are expanding their product portfolios and adopting innovative expansion strategies to meet these evolving demands through artificial intelligence. Further, regional-level analysis and forecasting play a vital role in understanding market dynamics and planning for future growth opportunities. With ongoing healthcare (R&D) research and advancements in diagnostic devices, the Blood-Grouping Reagents Market is poised for continued expansion to meet the evolving needs of the healthcare industry.

Market Scope
Report Coverage	Details
Page number	172
Base year	2023
Historic period	2018 - 2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 8.13%
Market growth 2024-2028	USD 520.68 million
Market structure	Fragmented
YoY growth 2023-2024(%)	7.67
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 45%
Key countries	US, Canada, UK, France, and Japan
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	AliveDX, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care Ltd., and VitroScient
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation of the size of the size and its contribution n of the market in focus to the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch